Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.129
Buy
RSI(14)
61.158
Neutral
STOCH(KDJ)(9,3,3)
82.668
Neutral
ATR(14)
1.149
Low Volatility
CCI(14)
80.590
Neutral
Williams %R
21.718
Buy
TRIX(12,20)
0.670
Sell
StochRSI(14)
0.000
Sell
Search
Azenta Inc
AZTAAdd to Watchlist
28.130USD
-0.670-2.33%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.30BMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-2.33%
5 Days
+2.78%
1 Month
+8.86%
6 Months
-25.05%
Year to Date
-15.42%
1 Year
-13.02%
Key Figures
29.040Open
29.040High
456.58KVolume
LossP/E TTM
45.69P/E Dynamic
--Dividend TTM
0.99%Turnover Ratio
28.800Prev. Close
27.820Low
8.71MTurnover
LossP/E Static
0.83P/B
0.00%Div Yield TTM
-5.62%ROA
41.73052wk High
0.73Volume Ratio
-55.76MNet Profit
46.09MShares
-3.7659EPS TTM
1.40Beta
-6.81%ROE
15.93052wk Low
4.24%Amplitude
-119.86%Gross Margin
1.30BMarket Cap
4.10Reward/Risk
2.97%Risk Rate
TradingKey Stock Score of Azenta Inc
Currency: USD Updated: 2026-07-31Key Insights
Azenta Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 25 out of 385 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 29.83.In the medium term, the stock price is expected to trend up.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Azenta Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
Azenta Inc Highlights
StrengthsRisks
Azenta, Inc. is a provider of life sciences solutions worldwide. The Company provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The Company's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Company's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The Company's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 593.82M.
Overvalued
The company’s latest PE is -7.47, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 52.28M shares, decreasing 8.52% quarter-over-quarter.
Held by Chuck Royce
Star Investor Chuck Royce holds 518.28K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.25.
Analyst Rating
Based on
7
analysts
Buy
Current Rating
29.833
Target Price
+6.06%
Upside Space
Azenta Inc News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
7
analysts
Buy
Current Rating
29.833
Target Price
+6.06%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Azenta Inc
AZTA
7
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
Kymera Therapeutics Inc
KYMR
24
Insmed Inc
INSM
23
1
2
3
...
99
Indicators
Moving Average
Indicators
Value
Direction
MA5
28.332
Sell
MA10
27.734
Buy
MA20
26.747
Buy
MA50
24.459
Buy
MA100
23.166
Buy
MA200
28.041
Buy
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Azenta Inc Info
Azenta, Inc. is a provider of life sciences solutions worldwide. The Company provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The Company's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Company's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The Company's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
Ticker SymbolAZTA
CompanyAzenta Inc
CEOMarotta (John)
Websitehttps://www.azenta.com/
Shareholders
Related Instruments
-0.53%
+0.27%
-2.51%
+0.32%
-1.45%
-0.92%
-0.64%
-0.82%
-8.79%
+0.52%
+0.68%
-0.95%
-0.71%
+0.44%
-1.08%
+3.29%
0.00%
-0.90%
+1.30%
-2.15%Popular Instruments
52784.700
+406.700 (+0.78%)
28547.600
+386.700 (+1.37%)
7536.900
+61.800 (+0.83%)
14665.000
-84.000 (-0.57%)
63668.000
+816.000 (+1.30%)
6408.700
+43.300 (+0.68%)
78.822
-7.112 (-8.28%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4069.340
+27.910 (+0.69%)
FAQs
What is the current price of Azenta Inc (AZTA)?
The current price of Azenta Inc (AZTA) is 28.13.
What is the symbol of Azenta Inc?
The ticker symbol of Azenta Inc is AZTA.
What is the 52-week high of Azenta Inc?
The 52-week high of Azenta Inc is 41.73.
What is the 52-week low of Azenta Inc?
The 52-week low of Azenta Inc is 15.93.
What is the market capitalization of Azenta Inc?
The market capitalization of Azenta Inc is 1.30B.
Is Azenta Inc (AZTA) currently rated as Buy, Hold, or Sell?
According to analysts, Azenta Inc (AZTA) has an overall rating of Buy, with a price target of 29.83.
What is the Earnings Per Share (EPS TTM) of Azenta Inc (AZTA)?
The Earnings Per Share (EPS TTM) of Azenta Inc (AZTA) is -1.22.